Recent studies are beginning to implicate sphingolipids in the heat stress response. In the yeast Saccharomyces cerevisiae, heat stress has been shown to activate de novo biosynthesis of sphingolipids, whereas in mammalian cells the sphingolipid ceramide has been implicated in the heat shock responses. In the current study, we found an increase in the ceramide mass of Molt-4 cells in response to heat shock, corroborating findings in HL-60 cells. Increased ceramide was determined to be from de novo biosynthesis by two major lines of evidence. First, the accumulation of ceramide was dependent upon the activities of both ceramide synthase and serine palmitoyltransferase. Second, pulse labeling studies demonstrated increased production of ceramide through the de novo biosynthetic pathway. Significantly, the de novo sphingolipid biosynthetic pathway was acutely induced upon heat shock, which resulted in a 2-fold increased flux in newly made ceramides within 1-2 min of exposure to 42.5°C. Functionally, heat shock induced the dephosphorylation of the SR proteins, and this effect was demonstrated to be dependent upon the accumulation of de novo-produced ceramides. Thus, these studies disclose an evolutionary conserved activation of the de novo pathway in response to heat shock. Moreover, SR dephosphorylation is emerging as a specific downstream target of accumulation of newly made ceramides in mammalian cells.
Recent studies are beginning to implicate sphingolipids in the heat stress response. In the yeast Saccharomyces cerevisiae, heat stress has been shown to activate de novo biosynthesis of sphingolipids, whereas in mammalian cells the sphingolipid ceramide has been implicated in the heat shock responses. In the current study, we found an increase in the ceramide mass of Molt-4 cells in response to heat shock, corroborating findings in HL-60 cells. Increased ceramide was determined to be from de novo biosynthesis by two major lines of evidence. First, the accumulation of ceramide was dependent upon the activities of both ceramide synthase and serine palmitoyltransferase. Second, pulse labeling studies demonstrated increased production of ceramide through the de novo biosynthetic pathway. Significantly, the de novo sphingolipid biosynthetic pathway was acutely induced upon heat shock, which resulted in a 2-fold increased flux in newly made ceramides within 1-2 min of exposure to 42.5°C. Functionally, heat shock induced the dephosphorylation of the SR proteins, and this effect was demonstrated to be dependent upon the accumulation of de novo-produced ceramides. Thus, these studies disclose an evolutionary conserved activation of the de novo pathway in response to heat shock. Moreover, SR dephosphorylation is emerging as a specific downstream target of accumulation of newly made ceramides in mammalian cells.
Mammalian cells undergo a heat shock response when the temperature is increased from 37°C. Cells respond to heat shock in a variety of ways; most prominent is the change in their pattern of gene expression resulting in the production of a specific subset of proteins termed heat shock proteins (1) . Many of the heat shock proteins produced upon heat shock function as chaperon proteins acting in the transport, assembly, and proper folding of proteins that ultimately affect survival of the cell (2) . However, prolonged exposure to heat shock conditions will result in either apoptosis or necrosis of mammalian cells (3) .
Sphingolipids have been implicated as bioactive molecules in mammalian cells; specifically, ceramide has been shown to have roles in differentiation (4), senescence (5) , and apoptosis (6) , leading to the proposal of ceramide as a stress-responsive lipid (7) . The accumulation of ceramide has been shown in response to heat shock in HL-60 (8, 9) and NIH WT-3T3 cells (10) . In NIH WT-3T3 cells N-acetylsphingosine (C 2 -ceramide) was proposed as an inducer of ␣B-crystallin transcription, possibly mirroring the effect of heat shock-produced ceramides in vivo (10) . Furthermore, C 2 -ceramide was shown to suppress heat-induced heat shock protein 70 production in HL-60 cells (9) . Also in HL-60 cells, the production of endogenous ceramide was shown to have a role in expression of c-jun/c-fos and activation of caspase-3, resulting in apoptosis of these cells upon heat shock. The source of the ceramide upon heat shock of HL-60 was proposed to derive from the hydrolysis of sphingomyelin through heat shock activation of the sphingomyelin cycle (8) .
In contrast to the sphingomyelin-derived production of ceramide is the yeast heat stress model. Production of phytoceramide and dihydroceramide in yeast heat stress has been determined to arise primarily through de novo biosynthesis (11, 12) . De novo biosynthesis starts with the activity of serine palmitoyltransferase, which condenses palmitoyl-CoA and serine to form keto-dihydrosphingosine. The keto-dihydrosphingosine is subsequently converted into dihydrosphingosine. The dihydrosphingosine is then acted upon by a (dihydro) ceramide synthase, catalyzing the addition of a fatty acid to the free amine of the sphingoid base.
Moreover, the accumulation of ceramide in response to etoposide has been described to arise through de novo biosynthesis in Molt-4 leukemic lymphocytes (13) . Other examples of de novo biosynthesis of ceramides have been shown to occur in response to receptor cross-linking in B cells (14) , Taxol treatment of MCF-7 and MDA-MB-468 breast cancer cells (15) , and nicotinamide treatment of normal human keratinocytes (16) among others. Furthermore, a recent link has also been made between the Fas-induced de novo biosynthesis of ceramide and the dephosphorylation of SR proteins, which form a family of proteins containing serine/arginine domains that regulate mRNA splicing (17) .
In light of the yeast heat stress findings, we investigated heat-shocked Molt-4 cells for an increase in ceramide and the possible role of de novo biosynthesis. The results of the current study show an accumulation of ceramide in Molt-4 cells with heat shock before the cells die or commit to apoptosis. The increased ceramide was found to arise primarily from an acute activation of de novo biosynthesis. Furthermore, heat shockinduced dephosphorylation of the SR proteins and the de novo production of ceramide was required for this dephosphoryl-ation. These results demonstrate an evolutionary conservation of regulation of the acute activation of the de novo sphingolipid pathway between yeast and human cells in response to heat shock. Moreover, the studies corroborate a specific role for this pathway in regulation of SR proteins.
EXPERIMENTAL PROCEDURES
Materials-Molt-4 acute leukemic lymphocytes and mAb104 (phospho-SR protein antibody) hybridoma cells were from ATCC (Manassas, VA). Myriocin was from Sigma. Fumonisin B1 was from Alexis Corp. Tritiated palmitate (9,10-3 H) was from ARC. ENHANCE was from PerkinElmer Life Sciences. PARP 1 antibody was from Santa Cruz Biochem. Trypan blue was from BioWhittaker.
Cell Culture-Human Molt-4 acute leukemic lymphocyte cells were maintained in RPMI 1640 (Invitrogen) containing 10% fetal bovine serum (Invitrogen) at 37°C in 5% CO 2 . Experimental studies were performed by diluting exponentially growing cells to 5 ϫ 10 5 cells/ml in RPMI 1640 containing 10% fetal bovine serum and 25 mM HEPES, pH 7.4. Samples rested for 2 h before treatment. Inhibitor studies were done with a 1-h preincubation of inhibitor after resting for 2 h. Samples were then split into controls (37°C) and heat-shocked samples (42.5°C).
Growth Studies-Cells were taken at the indicated time points from cultures at 37 and 42.5°C and diluted into trypan blue solution. Both trypan blue negative and positive cells were counted, and the percent of alive cells was determined.
Ceramide Mass and Species Measurements-Cells (2.5 ϫ 10 6 ) were collected by centrifugation (500 ϫ g). The resultant pelleted cells were lysed in chloroform:methanol (1:2), and lipids were extracted by the method of Bligh and Dyer (18) . The organic lipid extract was split into three equal aliquots. One aliquot was used to determine the organic phosphate of each sample, and the result was used to normalize the ceramide measurements. Another aliquot was used in the ceramide mass measurement previously described (19) using diacylglycerol kinase assay and thin layer chromatography (TLC) separation. For quantification, the plates were subsequently exposed to a phosphorimaging screen, scanned, and subsequently analyzed using ImageQuant. The other third of lipid was used for mass spectrometric analysis of ceramides by normal phase high performance liquid chromatography (HPLC) coupled to atmospheric pressure chemical ionization (14) . Briefly, separations were conducted using Iatrobead (Iatron Laboratories, Tokyo, Japan)-beaded silica columns utilized in a normal phase of operation. All mass spectrometric analyses were conducted on a Finnigan (Foster City, CA) LCQ ion trap mass spectrometer. For atmospheric pressure chemical ionization (APCI)-mass spectrometry, the entire flow from the HPLC column was directed to the APCI source. Adjustments were made to allow for identification of ceramide and dihydroceramide subspecies by combination of mass, intensity ratios in the mass spectrometry fragmentation pattern, and column retention. Additionally, no ionsuppressive matrix effects were observed. Calibration curves with synthetic standards showed equal ionization and thermal fragmentation of ceramide species from 40 fmol to 3500 pmol, regardless of fatty acid length.
Sphingoid Base Measurement-Cells (5 ϫ 10 6 ) were collected by centrifugation (500 ϫ g). Lipids were extracted as above and split into two aliquots, one-third for phosphate measurement and two-thirds for sphingoid base measurement. The measurement of sphingoid bases was performed as previously described (11, 20) Samples were compared by use of the nonendogenous sphingoid base L-threo-dihydrosphingosine as an internal standard added before lipid extraction and normalized to total organic phosphate.
Labeling Studies-Samples were seeded as noted in tissue culture, and then after the indicated pretreatments, they were labeled with 1 Ci/ml tritiated palmitate and incubated at either 37 or 42.5°C for the given length of time. Cells (2.5 ϫ 10 6 ) were collected by centrifugation (500 ϫ g) and washed once with water. Lipids were extracted as above and split into two aliquots, one-third for lipid phosphate measurement and two-thirds for sphingolipid analysis. Mild alkaline hydrolysis was performed on the aliquot for sphingolipid analysis. Lipids were then re-extracted as previously described (20) . Base-hydrolyzed lipids were then resuspended in chloroform:methanol:water (1:2:0.1) and spotted on a TLC plate. Lipids were developed in a solvent system of chloroform, methanol, 2 N NH 4 OH (4:1:0.1). Plates were dried, sprayed with ENHANCE, and exposed to film for 3 days. Where indicated bands of ceramide were scraped and analyzed by scintillation counting to obtain data for the percent of time-matched controls.
Microsome Preparation for in Vitro Serine Palmitoyltransferase and Ceramide Synthase Assays-Microsomes were prepared by sonication of cell pellets from Molt-4 cells in 25 mM Tris, pH 7.4, 5 mM EDTA, 1 mM phenylmethylsulfonyl fluoride containing 20 g/ml chymotrypsin, leupeptin, antipain, and pepstatin. The preparation was centrifuged at 1000 ϫ g, and the resulting supernatant was then ultracentrifuged at 100,000 ϫ g. The resultant pellet was suspended by homogenization in 25 mM Tris, pH 7.4, buffer containing 30% glycerol to form microsomes for the assays. Protein concentration was determined using the Bio-Rad dye binding reagents with a standard curve of bovine serum albumin.
In Vitro Serine Palmitoyltransferase Assay-Serine palmitoyltransferase activity was determined using microsome fractions isolated from heat-shocked and control cells essentially as described (21) . In brief, 100 g of microsomal protein was incubated at 37°C with shaking in 100 mM HEPES, pH 8.3, containing 5 mM dithiothreitol, 50 M pyridoxal-5Ј-phosphate, 5 mM [
3 H]serine (30,000 cpm/nmol), and 200 M palmitoyl CoA in a total volume of 200 l. After 20 min, reactions were stopped by the addition of 1.5 ml of CHCl 3 :CH 3 OH (1:2). Unlabeled sphingosine was added as carrier, and a phase separation was induced by the addition of 1 ml of CHCl 3 and 2 ml of 0.5 N NH 4 OH. The aqueous phase was removed, and the organic phase was washed two times with water. The resultant organic phase was dried under N 2 , and the extract was counted by liquid scintillation. Control experiments were performed to confirm the protein and palmitoyl CoA dependence of the reactions as well as to establish conditions showing linearity with time and protein concentration. Furthermore, the in vitro serine palmitoyltransferase activities were inhibitable by addition of myriocin to the assay.
In Vitro Ceramide Synthase Assay-Ceramide synthase activity was also determined for the microsome fractions essentially as described (22) . In short, 200 g of microsomal protein was incubated in 25 mM potassium phosphate, pH 7.4, containing 0.5 mM dithiothreitol, 200 M palmitoyl CoA, and 100 M [ 3 H]sphingosine (50 -100,000 cpm/nmol) delivered in phosphatidylcholine vesicles prepared by sonication. Incubations were performed for 20 min at 37°C and were stopped by the addition of 1 ml of CH 3 OH and vortexing followed by the addition of 1.5 ml of CHCl 3 , 50 g of cold ceramide as carrier, and 3 ml of water. Samples were vortexed and centrifuged to separate the phases. The aqueous phase was removed, and the organic phase was washed 2 times with 3 ml of slightly basic water, passed over an anhydrous sodium sulfate column prepared in a Pasteur pipette, and dried under N 2 . Analysis was done by dissolving samples in a small volume of CHCl 3 : CH 3 OH (2:1) and spotting onto silica TLC plates. Sphingosine and ceramide were spotted as standards. TLC plates were developed in CHCl 3 , CH 3 OH, 4 N NH 4 OH (40:10:0.1), and cold standards were visualized by iodine exposure. Plates were sprayed with ENHANCE and exposed to film. The areas corresponding to the cold ceramide and sphingosine spots were scraped and counted by liquid scintillation.
PARP and SR Western Blots-Cells were harvested by centrifugation (500 ϫ g) and washed in ice-cold phosphate-buffered saline. Proteins were extracted by direct lysis using Laemmli buffer (23) then were separated on 7.5% gels by SDS-PAGE and electrophoretically transferred to a nitrocellulose membrane (24) . Blots were blocked with 5% dried milk in 1ϫ phosphate-buffered saline containing 0.1% Tween 20 and then incubated with anti-PARP antibody at 1:1000. Bands were developed using the enhanced chemiluminescence (ECL Amersham Biosciences) detection system. The SR proteins were separated on a 10% SDS-PAGE and transferred as above to polyvinylidene difluoride membranes. The membranes were treated as described (17) .
RESULTS

Minimal Effects of Short Term Heat Shock on Cell Death and
PARP Cleavage-Molt-4 cells were exposed to heat shock of 42.5°C and compared with time-matched controls grown at the normal temperature of 37°C in the trypan blue exclusion assay. Heat shock for 4.5 h caused only 7.6% of the Molt-4 cells to die as compared with 5% of control cells. By 8.5 h of treatment, 20% of cells were dead. To determine whether the cells were already committed for the apoptotic program at earlier time points, PARP cleavage was determined by Western blotting. PARP is considered an early marker for the activation of the execution caspases, especially caspase 3. A small amount of the cleaved fragment could be discerned beginning at the 1-h time point and extending to the 4-h time point as compared with time-matched controls (Fig. 1) . These results corroborate the previous finding that short term exposure of SKT6 mouse erythroleukemia cells to 42°C for up to 6 h resulted in minimal caspase-3 activation, no DNA fragmentation, and little cell death (28) .
Heat Shock-induced Ceramide Accumulation-The total ceramide mass of heat-shocked cells was measured over a time course of up to 4 h and compared with time-matched controls. Total ceramide mass showed a small increase at 30 min (120.6 Ϯ 10.8%), rising to a 2-fold increase at 2 h (199.5 Ϯ 38.8%), and then to ϳ2.5-fold by 4 h (261.3 Ϯ 40.1%) ( Fig. 2A) . Therefore, heat shock increased the total ceramide mass in a time-dependent manner.
Total ceramides, as measured by the diacylglycerol kinase assay, are composed of a number of specific molecular species of both ceramide and dihydroceramide. The specificity of ceramide molecular species accounting for the heat-increased mass was determined using liquid chromatography-mass spectrometry analysis. The dihydroceramide species showed little or no increases upon heat shock for 2 h (Fig. 2B) . The ceramide species showed increases with C 18:0 , C 22:0 , and C 24:1 showing modest changes; however, the predominant form of ceramide at both temperatures was the C 16:0 form (Fig. 2C) , which increased nearly 2-fold upon heat shock for 2 h. These data indicate that a heterogeneous mixture of ceramide molecular species are increased upon heat shock and that the C 16:0 ceramide accounted for the majority of the increased ceramide mass observed in heat-shocked Molt-4 cells. 
Accumulation of Ceramide Mass from de Novo Biosynthesis upon Heat Shock-
We next investigated the source of increased ceramide mass in response to heat shock. The previous finding of the de novo production of ceramide upon heat stress in yeast and the accumulation of C 16:0 ceramide as the predominant species increased with heat shock, raised the possibility of activation of the de novo pathway. Therefore, we determined if the ceramide synthase inhibitor, fumonisin B1, could block the mass accumulation. Preincubation of Molt-4 cells with 100 M fumonisin B1 for 1 h completely inhibited the Ͼ2-fold increase of total ceramide mass (Fig. 3A) at 2 h.
These results led us to consider if the accumulation of ceramides required serine palmitoyltransferase activity. Preincubation of Molt-4 cells with the serine palmitoyltransferase inhibitor, myriocin, at 50 nM for 1 h also completely inhibited the increased mass of total cellular ceramide (Fig. 3A) . Analysis of the molecular species of total ceramides was performed to elucidate if only one particular species was produced through the activity of ceramide synthase and/or serine palmitoyltransferase. Fig. 3B shows that both pretreatment with myriocin or fumonisin B1 blocked the increases seen in C 16:0 , C 18:0 , C 22:0 , and C 24:1 ceramides. Taken together these data indicate that the aforementioned increased levels of ceramide derive initially through serine palmitoyltransferase activity and subsequent fatty acid addition by ceramide synthase. The findings are thus consistent with the production of ceramide via de novo biosynthesis.
Effects of Acute Activation of de Novo Biosynthesis by Heat Shock on Accumulation of Newly Made
Ceramide-Due to de novo biosynthesis activation, the mass of the endogenous sphingoid bases, sphingosine and dihydrosphingosine, was determined upon heat shock of Molt-4 cells. Overall, neither sphingosine nor dihydrosphingosine levels showed accumulation or loss during the 15-min to 2-h time course evaluated (data not shown).
To directly assess the role of de novo sphingolipid biosynthesis in cells, Molt-4 cells were pulse-labeled with tritiated palmitate. A portion of the palmitate is converted to palmitoyl-CoA in vivo and may be condensed with serine to form keto-dihydrosphingosine through the activity of serine palmitoyltransferase. Alternatively, palmitoyl-CoA may be directly N-linked onto a sphingoid base as the fatty acid attached by ceramide synthase forming C 16:0 ceramide. The bands labeled in Fig. 4A were identified using the following criteria. First, the total lipid extract was subjected to mild alkaline hydrolysis to which most glycerolipids are susceptible, whereas the sphingolipids are resistant. Next, each identified band co-migrated with known standards of the indicated compound. Finally, fumonisin B1 and myriocin pretreatment blocked the incorporation of tritiated palmitate into complex sphingolipids such as ceramide, cerebrosides, sphingomyelin, and gangliosides (Fig. 5) .
The initial labeling product accumulated with palmitate labeling was ceramide (Fig. 4A) . The possible intermediates of keto-dihydrosphingosine and dihydrosphingosine were not detected in the control or treated cells, correlating with the lack of accumulation of sphingoid bases. The incorporation of palmitate into ceramide continued to increase from 10 to 120 min ( Fig. 4A ) with no changes in the amount of palmitate taken up by heat-shocked cells as compared with controls. Expectedly, the de novo-produced ceramides in control cells were further incorporated into cerebrosides, sphingomyelin, and gangliosides starting at the 30-min time point and increasing through the time course. Somewhat unexpectedly, heat shock resulted in the augmentation of incorporation of palmitate into the complex sphingolipids, suggesting that heat shock induced an increase in the flux throughout the de novo pathway.
The finding of significant accumulation of newly made ceramides at the 10-min time point led us to investigate the rapidity of the up-regulation of production of de novo ceramides upon heat shock. Therefore, cells were labeled and immediately immersed into a heated water bath for 1, 2, or 5 min and compared with cells left at 37°C. Within 1 min of heat shock there was an increased incorporation of palmitate label into ceramide (175%) that continued to increase at 2-min (260%) and 5-min (285%) time points as compared with controls (Fig. 4B) . (9,10- 3 H) incorporation into sphingolipids with heat shock. Cells were pulse-labeled immediately before incubation at 37°C (C) or 42.5°C (HS) with 1 Ci/ml tritiated palmitate. Organic lipids were extracted, base-hydrolyzed, and separated on TLC. Plates were sprayed with ENHANCE and then were exposed to film. Data are representative of more than three experiments. B, treatment and analysis were done as above. Controls (Cont) were incubated at 37°C, and heat shock (HS) was at 42.5°C. Immediately before incubation at 37°C or 42.5°C, cells were pulse-labeled with 1 Ci/ml tritiated palmitate (9,10-3 H). Organic lipids were extracted, base-hydrolyzed, and separated on TLC. Plates were sprayed with ENHANCE and then exposed to film. Band designations were determined as noted in the text (under "Results"). Data are representative of more then three experiments. B, effects of myriocin on accumulation of ceramide. Molt-4 cells were preincubated with or without 50 nM myriocin (Myr) 1 h before treatment at 37°C (Cont) or 42.5°C (HS). Extraction and analysis were done as above. C, determination of in vitro serine palmitoyltransferase activity. Membrane proteins were isolated from heat-shocked Molt-4 cells at the times given. 100 g of extracted membrane protein was used to determine the in vitro serine palmitoyltransferase activity using 
De Novo Production of Newly Made Ceramides Is Dependent on Serine Palmitoyltransferase and Ceramide
Synthase Activities-To delineate the source of the labeled ceramide produced upon heat shock, the inhibitors of ceramide synthase and serine palmitoyltransferase were used in the palmitate-labeling studies. Pretreatment of 1 h with 100 M fumonisin B1 caused a nearly complete inhibition of the newly synthesized ceramide along with the complex sphingolipids (Fig. 5A) . These data show that accumulation of ceramide with the palmitate label proceeds through the fumonisin B1-inhibitable ceramide synthase(s).
Pretreatment of Molt-4 cells with 50 nM myriocin blocked most of the incorporation of the palmitate into ceramide formed upon heat shock (Fig. 5B) . Comparable with fumonisin B1 inhibition, myriocin inhibition also blocked the incorporation of palmitate label into the complex sphingolipids. Thus, heat shock induces the production of de novo ceramide, requiring both ceramide synthase and serine palmitoyltransferase activity.
The finding of the production of newly made ceramides upon heat shock led to the determination of the in vitro enzymatic activities for serine palmitoyltransferase and ceramide synthase. Measurement of serine palmitoyltransferase activity (Fig. 5C ) showed essentially no increased activity for microsomal protein harvested after 2.5 min (5.95 Ϯ 0.69 pmol of ketodihydrosphingosine/min/mg of protein), 5 min (5.32 Ϯ 1.03 pmol of keto-dihydrosphingosine/min/mg of protein), and 10 min (4.65 Ϯ 1.06 pmol of keto-dihydrosphingosine/min/mg of protein) of heat shock as compared with the 0-min control (5.18 Ϯ 0.71 pmol of keto-dihydrosphingosine/min/mg of protein). The in vitro ceramide synthase activity (Fig. 5D) for the microsomes was determined to be 224 Ϯ 31 pmol of ceramide/ min/mg of protein for the 0-min control. Protein extracted from heat-shocked cells at the 10 (246 Ϯ 14 pmol of ceramide/min/mg of protein)-, 30 (298 Ϯ 68 pmol of ceramide/min/mg of protein)-, and 60 (225 Ϯ 61 pmol of ceramide/min/mg protein)-min time points displayed essentially no increase of the in vitro ceramide synthase activity. Both sets of data showed no increased activity for the extracted proteins in the in vitro assays, ruling out induction of the proteins or post-translational modification as mechanisms of activation.
Requirement of de Novo Production of Ceramide in Inducing
Dephosphorylation of SR Proteins-Given the lack of significant cell death in this model system, we concentrated on specific downstream effects that could be mediated by ceramide. The accumulation of newly made ceramides was recently shown to result in the dephosphorylation of SR proteins (17) , and this effect was evaluated in our system. The proteins SR75p, SR55p, and Tra2p were dephosphorylated by 1 h of exposure to 42.5°C (Fig. 6) , coinciding with the initial ceramide mass accumulation (Fig. 2A) . The SR proteins continued to be in their dephosphorylated state at the 2-h time point (Fig. 6A) . Pretreatment with 50 nM myriocin inhibited the dephosphorylation of the SR proteins at both 1 and 2 h of heat shock (Fig.  6A) . Furthermore, SR protein dephosphorylation was also inhibited by fumonisin B1 pretreatment (Fig. 6B) at the 2-h time point. These data show that the induction of de novo ceramides mediated the dephosphorylation of the SR proteins in heatshocked Molt-4 cells.
DISCUSSION
Heat shock induced an increase in total ceramide mass, and two major lines of evidence from this study strongly suggest that the bulk of the increased levels of ceramides was produced through the de novo biosynthetic pathway. First, the activities of both ceramide synthase and serine palmitoyltransferase were required for ceramide accumulation. If only the ceramide synthase inhibitor fumonisin B1 had inhibited the increased mass of ceramide, these data would have indicated blocking of the recycling/salvage pathway, which could have been consistent with the breakdown of sphingomyelin. However, the inhibition observed with fumonisin B1 and myriocin demonstrated de novo biosynthesis, since myriocin inhibits serine palmitoyltransferase activity. Second, heat shock induced an acute activation of the production of de novo ceramides as determined by pulse labeling studies (Fig. 4) . Indeed, the exposure of Molt-4 cells to 42.5°C exerted an almost immediate induction of the sphingolipid biosynthetic pathway. The induction observed at 1 min is the most acute that has been described to date in relation to enzymes of sphingolipid metabolism, especially those involved in de novo biosynthesis. The heat shock-induced mechanisms regulating the flux through the sphingolipid biosynthetic pathway remain to be determined.
The dephosphorylation of SR proteins has been recently shown as a downstream effect of an accumulation of de novo ceramides through protein phosphatase 1 in response to Fas stimulation (17) . Heat shock was found to induce dephosphorylation of the SR proteins, and this effect was dependent upon biosynthesis of ceramides (Fig. 6) . In light of the combination of these findings, SR dephosphorylation is emerging as a specific downstream effect of de novo ceramide accumulation.
The heat-induced accumulation of ceramide observed in this study provides insight into sphingolipid metabolism while illustrating the complexity of this metabolism. An intriguing finding from the heat-induced ceramide mass accumulation was that myriocin and fumonisin B1 inhibited the increases seen in all the species of ceramide. These data indicate that the cells produce C 16:0 , C 18:0 , C 22:0 , and C 24:1 species through de novo biosynthesis (Fig. 3B) , suggesting that either ceramide synthase incorporates all of these fatty acyl species into ceramide and/or remodeling occurs soon after the formation of C 16:0 ceramide. Furthermore, the de novo accumulation of ceramides and not dihydroceramides was somewhat surprising, indicating a rapid conversion of newly made dihydroceramides into ceramides by dihydroceramide desaturase activity. This effect was not ob- served in other cell types with different inducers of de novo ceramide production; instead, both ceramide and dihydroceramide species increased. 2 The current findings raise the possibility that the desaturase may be particularly enriched in Molt-4 cells or activated by heat shock.
The labeling studies provide insight into the rate of synthesis of ceramide and regulation of this pathway. Interestingly, the first point of accumulation in the pulse-labeling experiments was at the ceramide level. Also to be noted was the increased production of sphingomyelin and glucosylceramides incorporating the labeled palmitate. These data indicate that although the clearance of ceramide by these enzymes was increased, it was not sufficient to overcome the de novo ceramide produced in response to heat shock, creating a bottleneck.
Furthermore, the lack of keto-dihydrosphingosine or dihydrosphingosine accumulation in the palmitate pulse labeling indicates a short life for these intermediates in the biosynthetic pathway. Another metabolic implication of the labeling studies was the lack of accumulation of sphingoid bases or sphingoid base phosphates with fumonisin B1 pretreatment, indicating an active sphingoid base phosphate lyase in the Molt-4 cells.
The lack of increased in vitro serine palmitoyltransferase and ceramide synthase activities indicates that there was no increase in the protein content of these enzymes upon heat shock of Molt-4 cells. The results also rule out stable posttranslational modifications as a mechanism for activation. However, the results do not rule out activation via an allosteric interaction or the driving of the enzymatic pathway by an increased availability of either serine or palmitate. The acuteness of activation and lack of in vitro effects may point to novel regulatory mechanisms for sphingolipid biosynthesis. These considerations are under investigation.
The total ceramide mass is composed of all cellular ceramides including newly made ceramides, ceramides from the breakdown of sphingomyelin and glucosylceramides, ceramide produced from the recycling/salvage pathway, and possibly pools of static (long-lived) ceramides. The activation of de novo sphingolipid biosynthesis required 2 h to achieve a 2-fold increase in the total mass of cellular ceramide, whereas this fold change in the flux in newly made ceramide was achieved within 2 min and was increased to 5-fold by 2 h. Thus, prolonged increase in flux is required to effect substantial changes in the mass of ceramide. This suggests at a first approximation that the half-life of ceramide is on the order of a few hours. Overall, the Molt-4 heat shock model could yield key information pertaining to the regulation of many sphingolipid metabolic enzymes.
The emergence of roles for sphingolipids in both the mammalian and yeast heat responses is beginning to define evolutionary-conserved sphingolipid signaling pathways. Both heat shock of Molt-4 cells and heat stress in yeast result in an acute activation of the de novo biosynthetic pathway of ceramide production (11, 12) . However, the yeast heat stress response involves a transient accumulation in the sphingoid bases that was not detected in Molt-4 cells. Furthermore, the transient accumulation of sphingoid bases upon heat stress of yeast cells was linked to trehalose accumulation (25) , a transient G 0 /G 1 cell cycle arrest (26) , and activation of a ubiquitin-dependent pathway leading to degradation of nutrient permeases (27) . However, biological functions for the increased ceramides observed with yeast heat stress have yet to be determined. In contrast, the current study of Molt-4 cells defines a role for heat-induced de novo ceramides in SR dephosphorylation.
Interestingly, the changes in sphingolipids in yeast exert a positive effect on their ability to survive and grow under heatstressed conditions. In contrast, ceramide has been implicated in activation of c-jun/c-fos, leading to activation of caspases and subsequent apoptosis in heat-shocked HL-60 mammalian cells (8) . However, the results from this study show that the changes in ceramide precede cell death and may not necessarily lead to cell death since these cells remain viable if removed from heat shock (data not shown). Therefore, sphingolipids may play a positive defensive role in responding to heat shock. Perhaps only when the damage is extensive (i.e. due to prolonged heat shock) do cells undergo apoptosis, a process that is still considered an overall protective mechanism in multicellular organisms.
Thus, the yeast heat stress model and the Molt-4 heat shock model are very complementary, and their study may lead to elucidation of fundamental mechanisms of heat-shock responses. In conclusion, the acute response of eukaryotic organisms to increased temperatures may emerge as a key model to understanding sphingolipid metabolism and function in stress responses.
